Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ML604086 suppresses CCL1 mediated chemotaxis and enhances intracellular Ca2 concentrations. ML604086 is a selective inhibitor of CCR8. It also inhibiting CCL1 binding to CCR8 on circulating T-cells.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 17,500 | |||
2 mg | 在庫あり | ¥ 25,000 | |||
5 mg | 在庫あり | ¥ 37,500 | |||
10 mg | 在庫あり | ¥ 66,000 | |||
25 mg | 在庫あり | ¥ 111,500 | |||
50 mg | 在庫あり | ¥ 159,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 42,000 |
説明 | ML604086 suppresses CCL1 mediated chemotaxis and enhances intracellular Ca2 concentrations. ML604086 is a selective inhibitor of CCR8. It also inhibiting CCL1 binding to CCR8 on circulating T-cells. |
分子量 | 508.63 |
分子式 | C27H32N4O4S |
CAS No. | 850330-18-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 105 mg/mL (206.44 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ML604086 850330-18-6 Immunology/Inflammation Microbiology/Virology CCR chemotaxis inhibit Inhibitor pro-inflammatory cytokine CC chemokine receptor ML-604086 T-cells asthma ML 604086 inhibitor